Back
Heartland Financial USA Vs. Keros Therapeutics Industry Stock Comparison
Sell
50
HTLF
Heartland Financial USA
Last Price:
60.70
Seasonality Move:
1.87%
Buy
60
KROS
Keros Therapeutics
Last Price:
60.76
Seasonality Move:
38.45%
Sell
50
Heartland Financial USA (HTLF)
is a Sell
Is Heartland Financial USA a Buy, Sell or Hold?
- The current Heartland Financial USA [HTLF] share price is $57.79. The Score for HTLF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- HTLF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $60.14. The Score for KROS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HTLF Stock Price Chart
What is Heartland Financial USA's stock price today?
-
The Heartland Financial USA share price today is $57.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HTLF is experiencing slight buying pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $60.14
The current trend is moderately bullish and KROS is experiencing slight buying pressure.
HTLF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.56 | Buy |
Relative Strength Index (14 RSI): | 52.62 | Buy |
Chaikin Money Flow: | 76369 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.53 - 58.69) | Buy |
Bollinger Bands (100): | (46.53 - 57.19) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.25 | Buy |
Relative Strength Index (14 RSI): | 55.64 | Buy |
Chaikin Money Flow: | 82977 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.66 - 61.04) | Buy |
Bollinger Bands (100): | (45.18 - 57.08) | Buy |
HTLF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.8 | Sell |
20-day SMA: | 57.36 | Buy |
50-day SMA: | 56.16 | Buy |
200-day SMA: | 44.41 | Buy |
8-day EMA: | 57.76 | Buy |
20-day EMA: | 57.47 | Buy |
50-day EMA: | 55.69 | Buy |
200-day EMA: | 47.05 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.01 | Buy |
20-day SMA: | 60.01 | Buy |
50-day SMA: | 55.19 | Buy |
200-day SMA: | 54.89 | Buy |
8-day EMA: | 60.09 | Buy |
20-day EMA: | 59.3 | Buy |
50-day EMA: | 56.32 | Buy |
200-day EMA: | 51.82 | Buy |
Heartland Financial USA Earnings Growth & HTLF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.05 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and a decrease next year of $0.49 per share.
Heartland Financial USA Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |